I will describe families of modular, therapeutic objects that can accomodate a variety of antiblastic drugs for future, non-conventional cancer treatment. The building blocks of our modular therapeutic objects are engineered natural proteins such as humanized antibodies, human ferritin, and streptavidin, as well as modified drugs including cisplatin, doxorubicin, and maytansinoids...